-
1 Comment
Biocorp Production is currently in a long term downtrend where the price is trading 9.4% below its 200 day moving average.
From a valuation standpoint, the stock is 93.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.7.
Based on the above factors, Biocorp Production gets an overall score of 1/5.
CurrencyCode | EUR |
---|---|
Exchange | PA |
ISIN | FR0012788065 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 155M |
---|---|
PE Ratio | None |
Target Price | 35.3 |
Dividend Yield | 0.0% |
Beta | 0.96 |
Biocorp Production designs, develops, and manufactures medical devices in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; Sween, a device that provides real assistance in the administration of medication and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France. As of August 4, 2023, Biocorp Production operates as a subsidiary of Novo Nordisk A/S.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALCOR.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025